2-propoxybenzamidine methane-sulphonate | 127824-94-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2-propoxybenzamidine methane-sulphonate
• 英文别名: 2-propoxybenzamidine methanesulphonate；2-propoxybenzamidine methanesulfonate；methanesulfonic acid;2-propoxybenzenecarboximidamide
• CAS: 127824-94-6
• 化学式: CH₄O₃S*C₁₀H₁₄N₂O
• 分子量: 274.341
• InChiKey: OSMIXDFUMIOXLR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.26
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  122
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-propoxybenzamidine methane-sulphonate 、 甲烷 、 3-氨基-4-甲酰胺基吡唑半硫酸盐 在 sodium acetate 作用下， 以 sodium hydroxide 为溶剂， 生成 6-(2-propoxyphenyl)pyrazolo[3,4-d]pyrimidin-4(5H)-one
  参考文献：
  名称：

  Pyrimidone derivatives as bronchodilators

  摘要：

  本发明涉及具有支气管扩张活性的融合嘧啶衍生物。本发明的一种化合物是2-(2-丙氧基苯基)噻吩[2,3-d]嘧啶-4(3H)-酮。

  公开号：

  US05075310A1

文献信息

• Method of treating a patient having precancerous lesions with phenyl purinone derivatives
  申请人：Cell Pathways, Inc.

  公开号：US06200980B1

  公开（公告）日：2001-03-13

  Derivatives of Phenyl Purinone are useful for the treatment of patients having precancerous lesions. These compounds are also useful to inhibit growth of neoplastic cells.

  苯基嘌呤酮衍生物对于治疗患有癌前病变的患者非常有用。这些化合物还可用于抑制肿瘤细胞的生长。
• Phenylpyrimidones
  申请人：Smith Kline & French Laboratories Limited

  公开号：US05118686A1

  公开（公告）日：1992-06-02

  This invention relates to phenylpyrimidone derivatives which have bronchodilator activity. A compound of the invention is 4-cyano-6-hydroxy-2-(2-propoxyphenyl)pyrimidine.

  本发明涉及具有支气管扩张剂活性的苯基嘧啶衍生物。该发明的一种化合物是4-氰基-6-羟基-2-(2-丙氧基苯基)嘧啶。
• Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives
  申请人：Cell Pathways, Inc.

  公开号：US06239136B1

  公开（公告）日：2001-05-29

  Derivatives of Phenyl Pyrimidinone are useful for the treatment of patients having precancerous lesions. These compounds are also useful to inhibit growth of neoplastic cells.

  苯基嘧啶酮的衍生物对于治疗患有癌前病变的患者非常有用。这些化合物也有助于抑制肿瘤细胞的生长。
• Method of treating a patient having precancerous lesions with phenyl
  申请人：Cell Pathways, Inc.

  公开号：US05874440A1

  公开（公告）日：1999-02-23

  Derivatives of Phenyl Pyrimidinone are useful for the treatment of patients having precancerous lesions. These compounds are also useful to inhibit growth of neoplastic cells.

  苯基嘧啶酮的衍生物对于治疗患有癌前病变的患者非常有用。这些化合物还可用于抑制肿瘤细胞的生长。
• Penylpyrimidone derivates and their use as therapeutic agents
  申请人：SMITH KLINE & FRENCH LABORATORIES LIMITED

  公开号：EP0395328A2

  公开（公告）日：1990-10-31

  Compounds of the formula (1) : and pharmaceutically acceptable salts thereof are described wherein R¹ is C₁₋₆alkyl, C₂₋₆alkenyl, C₃₋₅cycloalkylC₁₋₆alkyl, phenylC₁₋₆alkyl or C₁₋₆alkyl substituted by 1 to 6 fluoro groups; and R² is C₁₋₆alkyl, phenyl, hydroxy, C₁₋₆alkoxy, halo, -NHCOR³, -NHCONHR⁴, 5-tetrazolyl, -CO₂R⁵, cyano, -CONR⁶R⁷, or -NR⁸R⁹ wherein R³ to R⁷ are independently hydrogen or C₁₋₆alkyl and R⁸ and R⁹ are independently hydrogen or C₁₋₆alkyl optionally substituted by hydroxy provided that the carbon atom adjacent to the nitrogen atom is not substituted by hydroxy. Processes for their preparation, pharmaceutical compositions comprising them and their use as medicaments are also described.

  式 (1) ： 及其药学上可接受的盐，其中 R¹ 是 C₁₋₆烷基、C₂₋₆烯基、C₃₋₅烷基、苯基C₁₋₆烷基或被 1 至 6 个氟基团取代的 C₁₋₆ 烷基；而 R² 是 C₁₋₆烷基、苯基、羟基、C₁₋₆烷氧基、卤代、-NHCOR³、-NHCONHR⁴、5-四唑基、-CO₂R⁵、氰基、-CONR⁶R⁷、或-NR⁸R⁹，其中 R³ 至 R⁷ 独立地为氢或 C₁₋₆alkyl，R⁸ 和 R𠞙 独立地为氢或 C₁₋₆alkyl 可选地被羟基取代，条件是与氮原子相邻的碳原子未被羟基取代。 此外，还描述了它们的制备工艺、包含它们的药物组合物以及它们作为药物的用途。